Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma.

Ugocsai, Peter

Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma. [electronic resource] - British journal of haematology Jan 2016 - 290-3 p. digital

Publication Type: Case Reports; Letter

1365-2141

10.1111/bjh.13480 doi


Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Brentuximab Vedotin
Drug Administration Schedule
Female
Hodgkin Disease--drug therapy
Humans
Immunoconjugates--administration & dosage
Immunologic Factors--administration & dosage
Male
Positron-Emission Tomography
Remission Induction
Salvage Therapy--methods